EKB Journal Management System
1.

Impact of Functional Insulin Therapy on Glycemic Control in Type 1 Diabetics

2.

Inactive Matrix Gla Protein in Relation to Renal and Cardiac Functions in Type 2 Diabetes Patients

3.

Infection at Insulin Injection Site: An Educational Challenge

4.

Insulin resistance as a risk factor for metabolic-associated fatty liver disease (MAFLD) in non-obese individuals

5.

Investigating CD14 and CD16 in diabetics with nonalcoholic fatty liver disease associated with gonadal dysfunction

6.

Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study

7.

Knowledge, attitude, and practice among diabetic patients about diabetic foot disease in Khartoum state primary health care centers

8.

Lauric acid Ameliorates Non-alcoholic Fatty Liver Disease in Rats: Role of PI3K, IRS-1, Sirt1&K signaling pathways

9.

Malignant external otitis in diabetics: about 16 cases

10.

Maternally Inherited Diabetes and Deafness: Insights Into Mitochondrial Diabetes

11.

Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital

12.

Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade

13.

Neuropathic Pain in Obese Patients: Prevalence and Impact on Quality of Life

14.

Nonalcoholic fatty pancreas disease in relation to insulin resistance in Egyptian type 2 diabetic patients

15.

Optic Neuritis as a Mode of Revelation of Diabetes Mellitus

16.

Perirenal Fat Thickness in Relation to Glomerular Filtration Rate in Adult Males With Type 2 Diabetes

17.

Plasma Adiponectin and Its Correlation with Carotid Intima- Media Thickness in Obesity and in Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

18.

Prevalence, Phenotypic Distribution, And Clinical Characteristics of Polycystic Ovary Syndrome in Egyptian Women with Type 1 Diabetes Mellitus

19.

RANTES as a Novel Biomarker for Atherogenic Dyslipidemia and Metabolic Disturbances in Patients with Type-2 Diabetes

20.

Serum Level of Fetuin-A as A Biomarker for Vascular Complications and Severity of Insulin Resistance in Individuals with Type 2 Diabetes

21.

Stimulator of interferon genes/Interferon regulatory factor 3 (STING-IRF3) and inflammasome-activation mediated pyroptosis biomarkers: a network of integrated pathways in diabetic nephropathy

22.

Study and Clinical Significance of Urinary Levels of Glypican 5 in Diabetic Patients

23.

Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity

24.

The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways

25.

Urinary Immunoglobulin G as A Parameter for Early Detection of Chronic Kidney Disease in Patients with Metabolic Syndrome

26.

Using Digital Health Technology to Provide Comprehensive Care for Type II Diabetes Mellitus Patients.

27.

Wolfram Syndrome (DIDMOAD): A Rare Genetic Neurodegenerative Disorder

28.

B Cell Mass & Function & the Development of Type 2 DM

29.

Diffusion Tensor Imaging for Assessment of Bone Quality in Type 2 Diabetes and its relation to bone turnover markers